Metraipolis › archive › dc_c02fa7ac5e58

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study — Europe PMC PMID:42668534

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42668534
DOI
10.1016/j.cpt.2026.01.001
License (as archived)
solo-consultazione
Archived
2026-11-06T22:26:50.775Z
SHA-256 of the archived text
db6a03e54bb55bbe6e667e5efcc874a57dde7726bc67d599d428889f7dcc316a
Stable URL of this page
https://metraipolis.com/documento/dc_c02fa7ac5e58

How to cite

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study — Europe PMC PMID:42668534 — Europe PMC (en), https://europepmc.org/article/MED/42668534 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c02fa7ac5e58 (Metraipolis archive dc_c02fa7ac5e58, sha256 db6a03e54bb55bbe6e667e5efcc874a57dde7726bc67d599d428889f7dcc316a)
BibTeX
@misc{dcc02fa7ac5e58,
  title = {Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study — Europe PMC PMID:42668534},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42668534},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c02fa7ac5e58; sha256 db6a03e54bb55bbe6e667e5efcc874a57dde7726bc67d599d428889f7dcc316a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42668534. Agents can read the archived copy with the MCP tool read_document.